Within the cohort of 173 receptor‐positive tumours, the presence of a p63/p40+/SMA− cell population did not correlate with HER2 status, TP53 mutation, tumour grade, lymph node status, proliferation using different Ki67 cut‐offs, or Nottingham prognostic index (NPI), but patients were more likely to be disease free at the time of last follow up (Table 1). The gene discussed is TP63; the disease is neoplasm.